Evidence map›Paper›PMID 31829414›Full record

ArticleThe Journal of infectious diseases2020

Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?

Jaspreet Toor, David Rollinson, Hugo C Turner, Anouk Gouvras, Charles H King, Graham F Medley, T Déirdre Hollingsworth, Roy M Anderson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  3. Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  16. What Can Modeling Tell Us About Sustainable End Points for Neglected Tropical Diseases?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  17. Evaluating the potential impact of interruptions to neglected tropical disease programmes due to COVID-19.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Jaspreet ToorBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
David RollinsonDepartment of Life Sciences, Natural History Museum, London, UK.
Hugo C TurnerOxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.
Anouk GouvrasGlobal Schistosomiasis Alliance, Department of Life Sciences, Natural History Museum, London, UK.
Charles H KingCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.
Graham F MedleyCentre for Mathematical Modelling of Infectious Disease, London School of Hygiene and Tropical Medicine, London, UK.
T Déirdre HollingsworthBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
Roy M AndersonLondon Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
Natural History Museum · GBUniversity of Oxford · GBCenter for Global Health · USLondon School of Hygiene & Tropical Medicine · GB

Funding

Medical Research Council MR/R015600/1Wellcome Trust 089276/B/09/7
6 · The paper itself

Abstract

The World Health Organization (WHO) has set elimination as a public health problem (EPHP) as a goal for schistosomiasis. As the WHO treatment guidelines for schistosomiasis are currently under revision, we investigate whether school-based or community-wide treatment strategies are required for achieving the EPHP goal. In low- to moderate-transmission settings with good school enrolment, we find that school-based treatment is sufficient for achieving EPHP. However, community-wide treatment is projected to be necessary in certain high-transmission settings as well as settings with low school enrolment. Hence, the optimal treatment strategy depends on setting-specific factors such as the species present, prevalence prior to treatment, and the age profile of infection.

Indexed as

Schistosoma haematobiumSchistosoma mansoniAdolescentAdultAgedAnimalsChildChild, PreschoolCommunity Health ServicesHumansMass Drug AdministrationMiddle AgedModels, BiologicalPractice Guidelines as TopicPublic HealthSchistosomiasis haematobiacommunity-wide treatmentelimination as a public health problemmass drug administrationschistosomiasisschool-based treatment

Identifiers

PMID31829414
PMCPMC7289541
OpenAlexW3006267831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.